144 related articles for article (PubMed ID: 12102632)
1. DNA adducts formed from 4-hydroxytamoxifen are more mutagenic than those formed by alpha-acetoxytamoxifen in a shuttle vector target gene replicated in human Ad293 cells.
McLuckie KI; Routledge MN; Brown K; Gaskell M; Farmer PB; Roberts GC; Martin EA
Biochemistry; 2002 Jul; 41(28):8899-906. PubMed ID: 12102632
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots.
Liapis E; McLuckie KI; Lewis PD; Farmer PB; Brown K
Nucleic Acids Res; 2008 Oct; 36(18):5933-45. PubMed ID: 18805907
[TBL] [Abstract][Full Text] [Related]
3. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.
McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K
Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439
[TBL] [Abstract][Full Text] [Related]
4. Site-specific tamoxifen-DNA adduct formation: lack of correlation with mutational ability in Escherichia coli.
Lowes DA; Brown K; Heydon RT; Martin EA; Gant TW
Biochemistry; 1999 Aug; 38(34):10989-96. PubMed ID: 10460153
[TBL] [Abstract][Full Text] [Related]
5. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
Dasaradhi L; Shibutani S
Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the mutagenic activity of the benzene metabolites, hydroquinone and para-benzoquinone in the supF forward mutation assay: a role for minor DNA adducts formed from hydroquinone in benzene mutagenicity.
Gaskell M; McLuckie KI; Farmer PB
Mutat Res; 2004 Oct; 554(1-2):387-98. PubMed ID: 15450434
[TBL] [Abstract][Full Text] [Related]
7. Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen.
Terashima I; Suzuki N; Shibutani S
Cancer Res; 1999 May; 59(9):2091-5. PubMed ID: 10232593
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo.
Beland FA; McDaniel LP; Marques MM
Carcinogenesis; 1999 Mar; 20(3):471-7. PubMed ID: 10190564
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-DNA adducts formed by alpha-acetoxytamoxifen N-oxide.
Umemoto A; Monden Y; Komaki K; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
Chem Res Toxicol; 1999 Nov; 12(11):1083-9. PubMed ID: 10563834
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells.
Tompkins EM; McLuckie KI; Jones DJ; Farmer PB; Brown K
Mutat Res; 2009 Aug; 678(2):129-37. PubMed ID: 19477295
[TBL] [Abstract][Full Text] [Related]
11. Detection of tamoxifen-DNA adducts on lacI genes using DNA polymerase stop assay.
Cheng RH; Gant TW
Changgeng Yi Xue Za Zhi; 1999 Jun; 22(2):189-96. PubMed ID: 10493022
[TBL] [Abstract][Full Text] [Related]
12. Mutagenic events induced by 4-hydroxyequilin in supF shuttle vector plasmid propagated in human cells.
Yasui M; Matsui S; Laxmi YR; Suzuki N; Kim SY; Shibutani S; Matsuda T
Carcinogenesis; 2003 May; 24(5):911-7. PubMed ID: 12771036
[TBL] [Abstract][Full Text] [Related]
13. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells.
Juedes MJ; Wogan GN
Mutat Res; 1996 Jan; 349(1):51-61. PubMed ID: 8569792
[TBL] [Abstract][Full Text] [Related]
14. Kinds and spectrum of mutations induced by 1-nitrosopyrene adducts during plasmid replication in human cells.
Yang JL; Maher VM; McCormick JJ
Mol Cell Biol; 1988 Aug; 8(8):3364-72. PubMed ID: 3062380
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method.
Martin EA; Heydon RT; Brown K; Brown JE; Lim CK; White IN; Smith LL
Carcinogenesis; 1998 Jun; 19(6):1061-9. PubMed ID: 9667745
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system.
Endo H; Schut HA; Snyderwine EG
Cancer Res; 1994 Jul; 54(14):3745-51. PubMed ID: 8033094
[TBL] [Abstract][Full Text] [Related]
17. Comparing the frequency and spectra of mutations induced when an SV-40 based shuttle vector containing covalently bound residues of structurally-related carcinogens replicates in human cells.
Maher VM; Yang JL; Mah MC; McCormick JJ
Mutat Res; 1989; 220(2-3):83-92. PubMed ID: 2538743
[TBL] [Abstract][Full Text] [Related]
18. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
[TBL] [Abstract][Full Text] [Related]
19. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
[TBL] [Abstract][Full Text] [Related]
20. 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells.
Osborne MR; Davis W; Hewer AJ; Hardcastle IR; Phillips DH
Chem Res Toxicol; 1999 Feb; 12(2):151-8. PubMed ID: 10027792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
